Structural and biological evaluation of novel vanadium/Yttrium co-doped hydroxyapatite for bone tissue engineering applications
Source abstract
Abstract
Hydroxyapatite (HA) is widely used in various medical fields due to its exceptional bioactivity, bio-affinity, and biocompatibility. However, the potential of biomaterials co-doped with metal ions for specific biomedical applications remains underexplored. In this study, we modified the HA structure by introducing vanadium (V) and yttrium (Y) to enhance its physicochemical and biological properties. V-Y co-doped HA (V-Y:HA) samples were prepared by the wet precipitation method using a reflux condensation setup with three different concentrations (0.005 M, 0.01 M, and 0.02 M) of V and Y. The addition of V and Y significantly influenced the biochemical properties and crystal structure of HA. X-ray diffraction (XRD) analysis revealed a modified crystal structure and the presence of the β-tricalcium phosphate (β -TCP) phase in the sample with a higher V concentration. V and Y incorporation resulted in smaller crystallite sizes and noticeable changes in lattice parameters. Scanning electron microscopy (SEM) images displayed sphere-like morphology with extensive aggregation. Fourier-transform infrared spectroscopy (FT-IR) and Raman analysis confirmed the presence of functional groups and phosphate vibrational modes in V-Y:HA samples. X-ray photoelectron spectroscopy (XPS) revealed the ionic and oxide forms of vanadium and the electronic states of yttrium. The as-prepared samples exhibited excellent mechanical strength, reduced porosity, and improved hemocompatibility compared to pure HA. The V-Y:HA sample with a higher V concentration demonstrated enhanced antibacterial activity against P. aeruginosa and S. aureus. In-vitro bioactivity assessment after 21 days revealed enhanced apatite formation on the surface of HA and V-Y:HA materials. These findings suggest that the novel V-Y:HA nanomaterials have great potential as biomaterials for bone tissue engineering and related applications.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Chemical Synthesis and Characterization · Vanadium and Halogenation Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (84)
Show source-provided references
1. Investigation of the structural, photoluminescence properties, bioactivity and 5-fluorouracil delivery behavior of Dy3+ and Dy:Eu3+-doped bioactive glasses10.1016/j.jallcom.2023.169153 ↗
2. Discovering an unknown territory using atom probe tomography: elemental exchange at the bioceramic scaffold/bone tissue interface10.1016/j.actbio.2023.02.039 ↗
3. Hybrid gold/graphene oxide reinforced polycaprolactone nanocomposite for biomedical applications
4. The osteoinductivity of calcium phosphate-based biomaterials: a tight interaction with bone healing
5. Complex relationship between alumina and selenium-doped carbonated hydroxyapatite as the ceramic additives to electrospun polycaprolactone scaffolds for tissue engineering applications10.1016/j.jallcom.2019.06.013 ↗
6. Preparation and antimicrobial activity of the porous hydroxyapatite nanoceramics10.1016/j.jallcom.2018.03.162 ↗
7. Antimicrobial activity of hemocompatible silver doped hydroxyapatite nanoparticles synthesized by modified sol–gel technique10.1007/s13204-013-0197-x ↗
8. Magnesium influence on hydroxyapatite crystallization10.1016/0162-0134(93)80049-F ↗
9. Mechanism of incorporation of zinc into hydroxyapatite10.1016/j.actbio.2009.11.029 ↗
10. Strontium-substituted hydroxyapatite nanocrystals10.1016/j.ica.2006.07.074 ↗
11. Pharmacological properties of cerium compounds10.1007/s10254-004-0024-6 ↗
12. Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. II. Mechanisms of osteoblast adhesion10.1002/jbm.1247 ↗
13. Osteoblast response to hydroxyapatite doped with divalent and trivalent cations10.1016/j.biomaterials.2003.09.001 ↗
14. Novel multifunctional of magnesium ions (Mg++) incorporated calcium phosphate nanostructures10.1016/j.jallcom.2017.09.254 ↗
15. Zinc additions in calcium phosphate system. Phase behavior, microstructural and mechanical compatibility during sequential heat treatments10.1016/j.jallcom.2022.167173 ↗
16. Evaluation of the mechanical and corrosion protection performance of electrodeposited hydroxyapatite on the high energy electron beam treated titanium alloy10.1016/j.jallcom.2014.07.160 ↗
17. Health benefits of vanadium and its potential as an anticancer agent
18. Antidiabetic, chemical, and physical properties of organic vanadates as presumed transition-state inhibitors for phosphatases10.1021/acs.joc.5b02229 ↗
19. Vanadium in biological action: chemical, pharmacological aspects, and metabolic implications in diabetes mellitus10.1007/s12011-018-1540-6 ↗
20. Synthesis of nanostructured solid-state phases of V7O16 and V2O5 compounds for ppb-level detection of ammonia10.1016/j.jallcom.2016.03.116 ↗
21. Balance and tissue distribution of vanadium after short-term ingestion of vanadate10.1093/jn/112.12.2279 ↗
22. Intestinal absorption and secretion of radioactive vanadium (48VO-3) in rats and effect of Al(OH)310.1080/15287398209530246 ↗
23. Investigation of efficiency of a novel, zinc oxide loaded TEMPO-oxidized cellulose nanofiber based hemostat for topical bleeding10.1016/j.ijbiomac.2018.12.079 ↗
24. Influence of Zr4+ doping on structural, spectroscopic and conductivity studies of lithium titanium phosphate10.1016/j.ceramint.2014.05.111 ↗
25. Nano vanadium dioxide films deposited on biomedical titanium: a novel approach for simultaneously enhanced osteogenic and antibacterial effects10.1080/21691401.2018.1452020 ↗
26. Synthesis, characterization and in vitro anti-cancer activity of vanadium-doped nanocrystalline hydroxyapatite10.1039/C9NJ03406D ↗
27. Controlled compositions of tellurium/vanadium co-doped into hydroxyapatite/ϵ-polycaprolactone for wound healing applications10.1039/D2NJ00760F ↗
28. Vanadium(IV) complexes of salicylaldehyde-based furoic acid hydrazones: synthesis, BSA binding and in vivo antidiabetic potential10.1016/j.jinorgbio.2023.112232 ↗
29. Structural and biological properties of novel Vanadium and Strontium co-doped HAp for tissue engineering applications10.1016/j.ceramint.2023.06.272 ↗
30. Nanofibrous matrix of polycaprolactone embedded with zinc/vanadate doped hydroxyapatite: mechanical and in vitro cellular growth10.1016/j.jmrt.2021.11.138 ↗
31. Preparation and characterization of nanofibrous scaffolds of Ag/Vanadate hydroxyapatite encapsulated into polycaprolactone: morphology, mechanical, and in vitro cells adhesion
32. Physicochemical studies of iron/vanadate doped hydroxyapatite/polycaprolactone nanofibers scaffolds10.1016/j.molstruc.2022.132835 ↗
33. Synthesis and characterization of Y 2O 2S:Eu 3+, Mg 2+, Ti 4+ hollow nanospheres via a template-free route10.1016/j.jallcom.2012.07.060 ↗
34. Preparation, structure and temperature dependence of spectral properties of Yb3+/Er3+ doped Sr5(PO4)3F transparent glass ceramics10.1016/j.jallcom.2021.161018 ↗
35. In vivo changes of nanoapatite crystals during bone reconstruction and the differences with native bone apatite10.1126/sciadv.aay6484 ↗
36. Synergistic effects of novel superparamagnetic/upconversion HA material and Ti/Magnet implant on biological performance and long-term in vivo tracking
37. Nanomaterials for in vivo imaging10.1021/acs.chemrev.6b00073 ↗
38. The degradation regulation of 3D printed scaffolds for promotion of osteogenesis and in vivo tracking10.1016/j.compositesb.2021.109084 ↗
39. A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma10.1039/D1TB01136G ↗
40. He · Biol. Eff. · 2013
41. Synthesis and characterization of yttrium/hydroxyapatite nanoparticles10.4028/www.scientific.net/KEM.330-332.295 ↗
42. Synthesis of luminescent Mg-incorporated hydroxyapatite by reflux condensation method: Photoluminescence, in-vitro drug release and kinetic studies10.1016/j.matpr.2021.09.390 ↗
43. Simultaneous co-substitution of Sr2+/Fe3+ in hydroxyapatite nanoparticles for potential biomedical applications10.1016/j.ceramint.2018.08.187 ↗
44. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release10.1021/am300140q ↗
45. A comparative study of the sintering behavior of pure and manganese-substituted hydroxyapatite10.3390/ma8095308 ↗
46. Compositional complexity dependence of dislocation density and mechanical properties in high entropy alloy systems10.1016/j.pnsc.2020.07.002 ↗
47. Hydrothermal synthesis of porous triphasic hydroxyapatite/(α and β) tricalcium phosphate10.1007/s10856-008-3480-8 ↗
48. Green synthesis of Si-incorporated hydroxyapatite using sodium metasilicate as silicon precursor and in vitro antibiotic release studies10.1016/j.jphotobiol.2017.08.030 ↗
49. Comparison of the morphological and structural characteristic of bioresorbable and biocompatible hydroxyapatite-loaded biopolymer composites10.3390/nano11123194 ↗
50. Synthesis and characterisation of nanophase hydroxyapatite co-substituted with strontium and zinc10.1016/j.ceramint.2018.01.206 ↗
51. Physicochemical properties of hydroxyapatite modified with vanadium ions for degradation of methylene blue10.1016/j.molstruc.2021.130562 ↗
52. Fibrous growth of strontium substituted hydroxyapatite and its drug release10.1016/j.msec.2010.11.025 ↗
53. In vitro study of iron doped hydroxyapatite10.4236/jbpc.2013.44017 ↗
54. Synthesis, structural, optical, dielectric properties, gamma radiation attenuation, and antimicrobial activity of V-doped hydroxyapatite nanorods
55. Effects of strontium substitution on the structural distortion of hydroxyapatite by rietveld refinement and Raman Spectroscopy10.1016/j.ceramint.2019.02.194 ↗
56. Raman spectroscopy investigation of nano hydroxyapatite doped with yttrium and fluoride ions10.1080/00387010.2013.778296 ↗
57. A novel combination of graphene oxide / palladium integrated polycaprolactone nanocomposite for biomedical applications10.1016/j.diamond.2023.110033 ↗
58. Luminescent characteristics of layered yttrium oxide nano-phosphors doped with europium10.1063/1.4979209 ↗
59. Determination of the V2p XPS binding energies for different vanadium oxidation states (V5+ to V0+)10.1016/j.elspec.2004.03.004 ↗
60. Preparation of nanostructured manganese-doped biphasic calcium phosphate powders via sol-gel method
61. Z.Z. Hongyan Liu†, Fengjuan Chen, Pinxian Xi, Bin Chen, Liang Huang, Ju Cheng§, Changwei Shao, Jun Wang, Decheng Bai, Biocompatible Fluorescent Hydroxyapatite: Synthesis and Live Cell Imaging Applications, (n.d.).
62. Structural characterization, optical properties and in vitro bioactivity of mesoporous erbium-doped hydroxyapatite10.1016/j.jallcom.2015.05.064 ↗
63. Surface modification of hydroxyapatite nanocrystallite by a small amount of terbium provides a biocompatible fluorescent probe10.1021/jp8026463 ↗
64. Synthesis and investigation of physicochemical properties and biocompatibility of phosphate–vanadate hydroxyapatite Co-doped with Tb3+ and Sr2+ ions10.3390/nano13030457 ↗
65. Luminescence properties, energy transfer and thermal stability of white emitting phosphor Sr3(PO4)2:Ce3+/Tb3+/Mn2+for white LEDs10.1039/D1RA08062H ↗
66. Multiwalled carbon nanotubes enhance electrochemical properties of titanium to determine in situ bone formation10.1088/0957-4484/19/29/295101 ↗
67. Microstructural investigation into calcium phosphate biomaterials by spatially resolved cathodoluminescence10.1002/1521-4052(200102)32:2<130::AID-MAWE130>3.0.CO;2-Z ↗
68. Colloids and surfaces B: biointerfaces photoluminescence in the characterization and early detection of biomimetic bone-like apatite formation on the surface of alkaline-treated titanium implant: state of the art10.1016/j.colsurfb.2011.04.027 ↗
69. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges10.1039/D0MA00807A ↗
70. Nanosize hydroxyapatite: doping with various ions10.1179/1743676110Y.0000000005 ↗
71. Gold nanoparticles enriched graphene system for therapeutics: a novel combination of experimental and theoretical studies10.1007/s10904-023-02588-x ↗
72. Improvements in microstructural, mechanical, and biocompatibility properties of nano-sized hydroxyapatites doped with yttrium and fluoride10.1016/j.ceramint.2010.02.033 ↗
73. Mechanism of stress relaxation and phase transformation in additively manufactured Ti-6Al-4V via in situ high temperature XRD and TEM analyses10.1016/j.actamat.2020.02.056 ↗
74. Porosity-dependence of elastic moduli and hardness of 3Y-TZP ceramics10.1016/S0272-8842(98)00037-6 ↗
75. Effect of titania addition on yttria-stabilised tetragonal zirconia ceramics sintered at high temperatures
76. Mechanical basis of bone strength: influence of bone material, bone structure and muscle action
77. The potentiality of vanadium in medicinal applications10.1016/j.ica.2020.119445 ↗
78. Structural and dielectric properties of yttrium-substituted hydroxyapatites10.1016/j.msec.2014.11.039 ↗
79. Development and antibacterial activities of bacterial cellulose/graphene oxide-CuO nanocomposite films10.1016/j.carbpol.2019.115456 ↗
80. An in vitro evaluation of novel NHA/zircon plasma coating on 316L stainless steel dental implant10.1016/j.pnsc.2014.04.001 ↗
81. Anodic oxidation and hydrothermal treatment of titanium results in a surface that causes increased attachment and altered cytoskeletal morphology of rat bone marrow stromal cells in vitro10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-# ↗
82. Design of biocompatible polycaprolactone-based nanocomposite loaded with graphene oxide/strontium nanohybrid for biomedical applications
83. Development of porous ultra high molecular weight polyethylene scaffolds for the fabrication of orbital implant10.1007/s10934-006-9051-9 ↗
84. Engineering biocompatible implant surfaces: part i: materials and surfaces10.1016/j.pmatsci.2012.09.001 ↗